The therapeutic community is demonstrating considerable excitement in Asenlix, a relatively developed therapy designed to treat the impact of depression. Unlike common antidepressants that primarily focus on serotonin, Asenlix offers a unique mechanism of function, seemingly impacting multiple neurotransmitter networks involved in mental regulation